CDC20 and cancer: Some inhibitors have previously been reported to be effective in the treatment of cancers, including CFM-4, TAME/pro-TAME, Apcin, Withaferin A, NAHA, Ganodermanontriol and Mycophyto complex, Genistein, PRoTACs (CP5V), and BCHHD7c.[91,92] Recently, some novel compounds that target CDC20 have been reported.